Relaxo Footwears Ltd Valuation Shifts Signal Elevated Price Risk Amid Sector Dynamics

Valuation Metrics Signal Elevated Price Levels

Relaxo Footwears currently trades at a price of ₹365.40, up 2.68% from the previous close of ₹355.85. However, the stock’s valuation multiples have surged to levels that suggest a premium pricing environment. The price-to-earnings (P/E) ratio stands at a lofty 50.11, a significant increase that places the company firmly in the "very expensive" category according to recent grading updates. This is a marked change from its previous "expensive" status, reflecting heightened investor expectations or stretched price levels.

Complementing the P/E ratio, the price-to-book value (P/BV) has risen to 4.07, indicating that the market values the company at over four times its net asset value. Other enterprise value multiples also underscore this premium: EV to EBIT at 41.53 and EV to EBITDA at 24.07, both well above typical sector averages. The PEG ratio, which adjusts the P/E for earnings growth, is an elevated 9.55, signalling that the stock’s price growth far outpaces its earnings growth prospects.

Dividend yield remains modest at 0.83%, reflecting a conservative payout policy or reinvestment strategy, while return on capital employed (ROCE) and return on equity (ROE) are moderate at 9.74% and 8.13% respectively. These profitability metrics suggest that while the company is generating returns, they may not fully justify the stretched valuation multiples.

Peer Comparison Highlights Relative Valuation

When compared with peers in the footwear and allied sectors, Relaxo’s valuation stands out as particularly elevated. For instance, Metro Brands, another footwear player, trades at an even higher P/E of 68.67 and is also rated very expensive, while Bata India, despite a high P/E of 56.94, is considered attractive due to stronger underlying fundamentals. On the other hand, companies like Sheela Foam and Campus Activewear are rated very attractive with P/E ratios of 53.05 and 47.55 respectively, but with more favourable PEG ratios and profitability metrics.

Interestingly, some peers such as Redtape and Wakefit Innovations trade at lower P/E multiples of 30.65 and 27.16, with more reasonable PEG ratios, indicating potentially better value propositions. V-Guard Industries, although in a different segment, is also rated attractive with a P/E of 41.99 but a much higher PEG ratio, reflecting growth concerns. This peer context emphasises that Relaxo’s valuation premium is not universally justified across the sector.

Stock Performance Versus Market Benchmarks

Relaxo’s recent price action shows a mixed return profile when benchmarked against the Sensex. Over the past week, the stock has outperformed the index with a 4.34% gain compared to the Sensex’s decline of 0.79%. The one-month return is even more impressive at 24.07%, vastly exceeding the Sensex’s modest 1.04% rise. However, longer-term returns paint a less favourable picture. Year-to-date, Relaxo has declined by 9.60%, slightly better than the Sensex’s 10.58% fall, but over one year, the stock has underperformed with an 11.48% loss versus the Sensex’s 6.96% decline.

More concerning are the three- and five-year returns, where Relaxo has suffered steep losses of 59.38% and 68.93% respectively, while the Sensex has delivered robust gains of 20.99% and 45.68%. Even over a decade, Relaxo’s 52.79% gain pales in comparison to the Sensex’s 182.20% surge. This long-term underperformance raises questions about the sustainability of the current valuation premium.

Market Capitalisation and Analyst Ratings

Relaxo Footwears is classified as a small-cap company, which often entails higher volatility and growth potential but also greater risk. The recent MarketsMOJO grading has downgraded the stock from a "Hold" to a "Sell" rating as of 22 June 2026, reflecting concerns over valuation and return prospects. The Mojo Score stands at 42.0, reinforcing the cautious stance. This downgrade signals that analysts view the current price levels as unjustified by fundamentals and expect limited upside or potential downside risk.

Implications for Investors

The shift in Relaxo Footwears’ valuation from expensive to very expensive, combined with its modest profitability and underwhelming long-term returns, suggests that investors should exercise caution. The elevated P/E and PEG ratios imply that much of the company’s growth potential is already priced in, leaving limited margin for error. Furthermore, the downgrade to a "Sell" rating by MarketsMOJO underscores the risk of valuation correction if earnings growth fails to accelerate meaningfully.

Investors should also consider the broader footwear sector dynamics and peer valuations. While some competitors offer more attractive valuations and better growth prospects, Relaxo’s premium pricing demands strong operational execution and market share gains to justify its current multiples. The moderate dividend yield further limits income appeal, making capital appreciation the primary driver of returns.

Given the stock’s recent outperformance in the short term, momentum traders may find opportunities, but fundamental investors should weigh the risks carefully. The company’s small-cap status adds an additional layer of volatility, which may not suit risk-averse portfolios.

Conclusion

Relaxo Footwears Ltd’s valuation parameters have shifted notably, with the stock now classified as very expensive based on key multiples such as P/E, P/BV, and EV/EBITDA. Despite some short-term price gains, the company’s long-term returns lag behind the broader market, and profitability metrics remain moderate. The recent downgrade to a "Sell" rating by MarketsMOJO reflects these concerns, signalling that investors should approach the stock with caution. Peer comparisons reveal that more attractively valued alternatives exist within the footwear sector, which may offer better risk-adjusted returns. Ultimately, the elevated valuation demands strong future performance to sustain current price levels, making it essential for investors to monitor earnings trends and sector developments closely.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →